$RUBY
Rubius Therapeutics Inc
PRICE
$1.09 โฒ0.926%
Extented Hours
VOLUME
1,077,468
DAY RANGE
0.9606 - 1.12
52 WEEK
0.9606 - 29.06
Key Metrics
Market Cap
91.12 M
Beta
2.08
Avg. Volume
1.77 M
Shares Outstanding
90.21 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-08
Next Dividend Date
Company Information
Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeuticsโข. The Company's proprietary RED PLATFORMยฎ was designed to genetically engineer and culture Red Cell Therapeuticsโข that are selective, potent and off-the-shelf allogeneic cellular therapies for the potential treatment of several diseases across multiple therapeutic areas.
CEO: Pablo Cagnoni
Website: www.rubiustx.com
HQ: 399 Binney St Ste 300 Cambridge, 02142-1038 Massachusetts
Related News